Status:
COMPLETED
Tedizolid Suppressive Antimicrobial Therapy in a Reference Center
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Bone and Joint Infection
Eligibility:
All Genders
Brief Summary
the aim of the study is to describe the management and outcome of patients having an osteo-articular infection treated by tedizolid as a suppressive antibiotic therapy.
Eligibility Criteria
Inclusion
- patients having an osteo-articular infection treated with tedizolid as a suppressive antibiotic therapy
Exclusion
- \-
Key Trial Info
Start Date :
February 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2021
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT04662736
Start Date
February 1 2021
End Date
April 1 2021
Last Update
June 21 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospices Civils de Lyon
Lyon, France, 69004